<--- Back to Details
First PageDocument Content
Finasteride / Benign prostatic hyperplasia / 5-alpha-reductase inhibitor / Transurethral resection of the prostate / Prostate cancer / Urinary retention / Testosterone / Dihydrotestosterone / Merck & Co. / Medicine / Lactams / Androgens
Date: 2010-10-05 09:53:16
Finasteride
Benign prostatic hyperplasia
5-alpha-reductase inhibitor
Transurethral resection of the prostate
Prostate cancer
Urinary retention
Testosterone
Dihydrotestosterone
Merck & Co.
Medicine
Lactams
Androgens

Proscar (finasteride) tablets label

Add to Reading List

Source URL: www.accessdata.fda.gov

Download Document from Source Website

File Size: 346,07 KB

Share Document on Facebook

Similar Documents

Testosterone Rex: Unshackling communities from a gendered mindset Communities in Control Conference Melbourne, Tuesday, May 30, 2017 An address on gender equality by

DocID: 1v1v9 - View Document

Testosterone therapy (TTh) prevents progression from prediabetes to type 2 diabetes (T2DM) in hypogonadal: 9-year data from a registry study F Saad1,2, KS Haider3, A Haider3 1Global

DocID: 1uJuK - View Document

Testosterone up-regulation, a tricky issue There is sample of evidence that a sufficiently high testosterone level is absolutely essential to a sexualized lifestyle. Testosterone, the hormone primarily synthe

DocID: 1ufIo - View Document

1 Medication Guide AXIRON® (AXE-e-RON) (testosterone) topical solution, for topical use CIII What is the most important information I should know about AXIRON?

DocID: 1twMw - View Document

1 Medication Guide AXIRON® (AXE-e-RON) (testosterone) topical solution, for topical use CIII What is the most important information I should know about AXIRON?

DocID: 1tuS3 - View Document